Skip to main content
Premium Trial:

Request an Annual Quote

Phthisis Diagnostics Raises $410,000

NEW YORK (GenomeWeb News) – Phthisis Diagnostics announced recently it has raised $410,000 in a second round of angel funding.

The money will be used to continue marketing its products and to expand its product lines, Crystal Icenhour, president and CSO of the Charlottesville, Va.-based company said. The money will go toward completing the development and clinical trials for Phthisis' first diagnostic for parasites, which is expected to be launched within the next 18 months, she added, and additional diagnostics for fungi mycobacterium, as well as molecular standards for improved laboratory quality control, are also being developed.

Original investors in the firm, Piedmont Angel Network and New Dominion Angels, contributed $147,500 to the round, while seven other investors committed an additional $262,500. New investors in the round include Piedmont Investment Advisors, through its affiliate Militello Capital; MooDoos Limited Partnership; Ronald Harris; Virga Ventures; Daniel Brody; and Afton Scientific NA.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.